Frontlight ResearchEarly access
Active, not recruitingNo phase
An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients
Key facts
- Who runs it
- Shengjing Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 2,000 people, planned
- Started
- 1 Jan 2011
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Treatments tested
- retrospective observational study
- Record updated
- 11 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- age of ≥ 18 years and a pulmonary embolism diagnosis based on CT pulmonary angiography
Who cannot take part
- missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels
- pregnancy
- reception of reperfusion treatment before admission
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This multi-center retrospective study collected clinical, laboratory, and CT pulmonary angiography parameters with acute pulmonary embolism patients from admission to predict adverse outcomes within 30 days after admission into hospital.
Treatments tested
- retrospective observational study
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 11 March 2026